The addition of interferon or high dose
✍
Martin M. Oken; Traci Leong; Raymond E. Lenhard Jr.; Philip R. Greipp; Neil E. K
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 133 KB
👁 2 views
## BACKGROUND. Interferon (IFN) has demonstrated activity in the treatment of patients with multiple myeloma. A previous Eastern Cooperative Oncology Group (ECOG) study suggested that the rates of complete response (CR) and survival were increased with a regimen that alternated IFN with chemothera